Incorporation of fatty acids into phospholipids has been investigated using samples of rat liver homogenate, Krebs-Ringer phosphate buffer (pH=7.4 ) containing 0.3% albumin, fatty acid mixture and glycerol. The addition of neopterin, serotonin (0.2 and 2.0 nmoljg wet weight) without iproniasid and 5-hydroxyindoleacetic acid (20.0 nmoljg wet weight) induced an increase of saturated and a decrease of unsaturated, especially arachidonic acid, incorporation into phospholipids. These changes were accompanied with elevated cholesterol content in samples. The addition of 5,6,7,8-tetrahydrobiopterin (5 and 30 pmolj g wet weight) and serotonin (0.2 and 2.0 nmoljg wet weight) together with iproniasid (10 nmoljg wet weight) to incubation medium for phospholipid biosynthesis in vitro induced a decrease of saturated and an increase of unsaturated, especially arachidonic acid, incorporation into phospholipids. These changes were accompanied with decreased cholesterol content in samples. The influence of serotonin without iproniasid and 5-hydroxyindoleacetic acid was similar to that of neopterin, kynurenine and noradrenaline observed earlier, while the influence of serotonin together with iproniasid was similar to that of 5,6,7,8-tetrahydrobiopterin and its precursors found earlier. Our results allow to suggest that in the studied concentrations serotonin increases, while 5-hydroxyindoleacetic acid decreases membrane fluidity .
Introduction
The results of our previous investigations showed that pteridines and kynurenines may take part in the regulation of cell cycle possibly by influencing membrane fluidity (1, 2, 3, 4, 5) . Pteridines, especially tetrahydrobiopterin, participate in the tryptophan metabolism : 5 ,6,7,8-tetrahydrobiopterin is a cofactor necessary for the conversion of tryptophan to 5-hydro~~tryptophan (6 ) , the precursor of 5-h ydroxy-tryptamine (serotonin). Serotonin is a key metabolite in to rmation of melatonin, which is known as one of the strongest biological antioxidants (7) . It is also splitted to 5-hydroxyindoleacetic acid, one of the end products of the serotonin pathway by monoaminooxidase (amine: O 2 oxidoreductase, EC 1.4.3.4), a widely distributed enzyme system in tissues (8, 9 ) . It is known that low (physiological) doses of serotonin induce vasodilation followed by a decrease of arterial blood pressure while high doses of serotonin induce vasoconstriction followed by an increase of arterial blood pressure (8) . Permanent high doses of serotonin were followed by atherosclerosis of coronary arteries as well as fibrotic thickness of tricuspidal, mitral and aortical valve in dogs and tissue necrosis of fingers in rats (9 ) . The aim of this study was to examine the effect of serotonin, iproniasid, an inhibitor of amine: O 2 oxidoreductase, and 5-hydroxyindoleacetic acid on fatty acid incorporation into phospholipids as well as on cholesterol and phospholipid content. In this context some investigations with 5,6,7,8-tetrahydrobiopterin and neopterin were repeated as control experiments.
Methods
Homogenized liver tissue of 28 male Wistar rats in Krebs-Ringer-phosphate buffer (pH=7.4) containing 0 .3% albumin were used for these experiments (10, 11) . Control and experimental samples were incubated two times for 4 hours . ( 12) . The whole cholesterol concentration was determined by the method of Engelhard and Srnirnova ( 13) , the amount of phospholipids by the method of Urbach-Raabe (14) . The method of Kates (15) was used to prepare the phospholipid samples for fatty acid examination by gas chromatography. Helium was used as a carrier gas and the sorbent was chromosorb covered with DEAG. Separated fatty acid methylesters were monitored at 210°C, using flame ionization detection and an adequate flow rate of helium. Statistical analyses were done using Student's ttest. P -values below 0.05 were considered to indicate significant differences (16) . while the amount of phospholipids was not altered. Figure 3 shows the changes of phospholipid biosynthesis after addition of serotonin without an inhibitor of monoamine oxidase to samples. An increase of stearic and linolenic acid and a decrease of arachidonic acid incorpororation into phospholipids were found. The cholesterol content increased in samples contammg serotonin, w hile the amount of phospholipids remained unchanged. cholesterol in samples. Nevertheless, if compared with the controls, we found a little amount of 8,11 , 14,17 -arachidonic acid in phospholipids of some samples incubated with iproniasid. Figure 5 shows the influence of S-hydroxyindole acetic acid on phospholipid biosynthesis in vitro. We saw an increase of stearic and a decrease of oleic, linoleic and arachidonic acid incorporation into phospholipids. The cholesterol content \vas elevated, while the amount of phospholipids was not altered in samples.
Results

Discussion
The results observed after addition of neopterin and tetrahydrobiopterin to incubation medium for phospholipid biosynthesis in vitro agree with the data received in our previous studies (1, 2) . The addition of serotonin without iproniasid and the addition of S-hydroxyindoleacetic acid to incubation medium for phospholipid biosynthesis
In vitro show the similar results. These metabolites stimulate the incorporation of saturated and depress the incorporation of unsaturated fatty acids into phospholipids . These deviations of fatty acid incorporation are accompanied with elevated cholesterol content in samples. The data of our previous observations show that similar changes have been found in experiments with neopterin, kynurenine and norepinephrine (I). Liver tissue is rich with amine: O 2 oxidoreductase (8, 9) . It allows us to suggest that in the experiments using serotonin without iproniasid addition a relevant percentage of serotonin can be converted to S-hydroxyindoleacetic acid. Interestingly, an inverse relationship was observed after addition of serotonin together with iproniasid to incubation medium tor phospholipid biosynthesis in vitro. Then serotonin depressed the incorporation of saturated and stimulated the incorporation of unsaturated, especially arachidonic acid, into phospholipids. These changes were accompanied by a decrease of cholesterol and an increase of phospholipid content in samples. In fact, these changes in lipid metabolism are similar to those observed after addition of S,6,7,S-tetrahydrobiopterin and its precursors to the same assay system (2) .
From the data of literature we know that the cholesterol/phospholipid ratio, cholesterol content and fatty acid composition of phospholipids are important in the regulation of membrane fluidity. High cholesterol content, high cholesterol/ phospholipid ratio and high concentration of saturated fatty acids in phospholipids are characteristic for a decrease of membrane tluidin', for inhibiting contact benyeen cells and for depression of cell cycle , \yhile low cholesterol concentration, 100y cholesterol/ phospholipid ratio and unsaturated fatt\ ' acid composition 111 phospholipids are followed by an increase of membrane tluidity, by activating contact between cells and by stimulation of cell cycle (17,lS) . Therefore the results of this study allow us to suggest that serotonin per se increases membrane fluidity and stimulates the cell cycle, while the end product of the serotonin pathway, S-hydroxyindoleacetic acid, decreases membrane fluidity and depresses cell cycle. The results of this study allow also to suggest that in the presence of liver homogenate a lot of serotonin can be converted to S-hydroxyindoleacetic acid during S hours.
